Total Payments
$4,232
2024 Payments
$720.17
Companies
32
Transactions
141
Medicare Patients
6,387
Medicare Billing
$437,304
Payment Breakdown by Category
Food & Beverage$2,866 (67.7%)
Travel$1,113 (26.3%)
Education$197.10 (4.7%)
Other$55.71 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,866 | 130 | 67.7% |
| Travel and Lodging | $1,113 | 7 | 26.3% |
| Education | $197.10 | 3 | 4.7% |
| Grant | $55.71 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $703.59 | 28 | $0 (2021) |
| Olympus Corporation of the Americas | $680.77 | 9 | $0 (2018) |
| Intuitive Surgical, Inc. | $622.40 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $426.29 | 19 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $234.17 | 6 | $0 (2023) |
| UROGEN PHARMA, INC. | $188.48 | 3 | $0 (2024) |
| ABBVIE INC. | $177.93 | 18 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $102.04 | 6 | $0 (2022) |
| PFIZER INC. | $101.57 | 5 | $0 (2024) |
| Teleflex LLC | $95.22 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $720.17 | 31 | Astellas Pharma US Inc ($124.11) |
| 2023 | $1,079 | 17 | Intuitive Surgical, Inc. ($622.40) |
| 2022 | $670.46 | 44 | Astellas Pharma US Inc ($213.56) |
| 2021 | $478.41 | 17 | BOSTON SCIENTIFIC CORPORATION ($229.74) |
| 2020 | $64.89 | 5 | Boston Scientific Corporation ($52.13) |
| 2019 | $394.07 | 15 | Boston Scientific Corporation ($366.01) |
| 2018 | $73.14 | 4 | Olympus Corporation of the Americas ($60.97) |
| 2017 | $751.84 | 8 | Olympus Corporation of the Americas ($619.80) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 11/18/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/30/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Laborie Medical Technologies Corp. | Urgent PC Neuromodulation System (Device) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: Urology | ||||||
| 10/24/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $47.09 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/21/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/01/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/06/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $23.02 | General |
| Category: Urology | ||||||
| 08/14/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Urology | ||||||
| 06/27/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $23.23 | General |
| 06/26/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Pain Management | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: ONCOLOGY | ||||||
| 04/15/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/28/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 02/28/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,921 | 5,928 | $851,550 | $210,373 |
| 2022 | 39 | 2,844 | 5,373 | $661,890 | $189,873 |
| 2021 | 15 | 622 | 701 | $99,215 | $37,058 |
Total Patients
6,387
Total Services
12,002
Medicare Billing
$437,304
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 45 | 405 | $253,125 | $54,634 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 378 | $75,600 | $28,944 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 316 | 378 | $51,030 | $19,624 | 38.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 99 | 125 | $56,250 | $18,541 | 33.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 37 | 43 | $86,000 | $12,015 | 14.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $21,600 | $5,801 | 26.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 228 | 307 | $24,560 | $5,532 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $17,700 | $5,437 | 30.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 13 | 13 | $25,350 | $4,874 | 19.2% |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | Office | 2023 | 33 | 121 | $6,050 | $4,161 | 68.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 19 | $11,400 | $3,998 | 35.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 25 | 25 | $12,500 | $3,965 | 31.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 45 | 50 | $15,250 | $3,835 | 25.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 32 | 38 | $45,600 | $3,215 | 7.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 278 | 368 | $7,360 | $3,076 | 41.8% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 15 | $10,500 | $2,797 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 24 | $6,360 | $2,643 | 41.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $8,250 | $2,632 | 31.9% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 96 | 130 | $10,400 | $2,356 | 22.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 40 | 41 | $8,200 | $2,284 | 27.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 13 | 13 | $11,050 | $2,135 | 19.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 58 | $4,350 | $1,939 | 44.6% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 43 | 47 | $2,350 | $1,616 | 68.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 34 | $5,780 | $1,614 | 27.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 319 | 511 | $10,220 | $1,584 | 15.5% |
About Dr. Matthew Davis, M.D
Dr. Matthew Davis, M.D is a Urology healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1740639533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Davis, M.D has received a total of $4,232 in payments from pharmaceutical and medical device companies, with $720.17 received in 2024. These payments were reported across 141 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,866).
As a Medicare-enrolled provider, Davis has provided services to 6,387 Medicare beneficiaries, totaling 12,002 services with total Medicare billing of $437,304. Data is available for 3 years (2021–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Union City, TN
- Active Since 06/13/2016
- Last Updated 03/21/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1740639533
Products in Payments
- ShockPulse - SE (Device) $680.77
- Da Vinci Surgical System (Device) $622.40
- AMS (Device) $318.48
- PROLARIS (Device) $189.44
- JELMYTO (Drug) $188.48
- XIAFLEX (Biological) $170.38
- XTANDI (Drug) $152.68
- LUPRON DEPOT (Drug) $133.90
- GENERAL ERECTILE DYSFUNCTION (Device) $129.51
- Myrbetriq (Drug) $128.51
- SPACEOAR VUE (Device) $100.23
- UROLIFT (Device) $95.22
- REZUM (Device) $88.23
- Xtandi (Drug) $76.57
- Cook Medical Stents (Device) $76.33
- ORGOVYX (Drug) $72.05
- ADSTILADRIN (Biological) $65.67
- GEMTESA (Drug) $58.61
- GENERAL - ERECTILE DYSFUNCTION (Device) $55.71
- AQUABEAM ROBOTIC SYSTEM (Device) $47.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.